These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20357287)

  • 1. Chemoprevention of prostate cancer.
    Walsh PC
    N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of prostate cancer.
    Stephenson AJ; Abouassaly R; Klein EA
    Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tests for prostate cancer may be nearing the clinic.
    Tuma RS
    J Natl Cancer Inst; 2010 Jun; 102(11):752-4. PubMed ID: 20498428
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.
    Helfand BT; Blackwell RH; McVary KT
    J Urol; 2010 Jul; 184(1):218-23. PubMed ID: 20483154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finasteride to prevent prostate cancer: a new chapter.
    Harv Mens Health Watch; 2009 Jun; 13(11):1-4. PubMed ID: 19579321
    [No Abstract]   [Full Text] [Related]  

  • 6. Dutasteride and prostate cancer.
    Garattini S; Bertele' V
    N Engl J Med; 2010 Aug; 363(8):794; author reply 794-6. PubMed ID: 20842790
    [No Abstract]   [Full Text] [Related]  

  • 7. Dutasteride and prostate cancer.
    Klotz L
    N Engl J Med; 2010 Aug; 363(8):794; author reply 795-6. PubMed ID: 20842791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dutasteride provides chemoprevention].
    Werner F
    Aktuelle Urol; 2006 Sep; 37(5 Suppl):18. PubMed ID: 23646395
    [No Abstract]   [Full Text] [Related]  

  • 9. Dutasteride and prostate cancer.
    Schröder FH; Roobol MJ
    N Engl J Med; 2010 Aug; 363(8):793-4; author reply 794-5. PubMed ID: 20842789
    [No Abstract]   [Full Text] [Related]  

  • 10. High-grade prostate cancer and finasteride.
    Lebdai S; Bigot P; Azzouzi AR
    BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost utility of prostate cancer chemoprevention with dutasteride in men with an elevated prostate specific antigen.
    Svatek RS; Lotan Y
    Cancer Prev Res (Phila); 2011 Feb; 4(2):277-83. PubMed ID: 21163937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins may slow prostate growth.
    Printz C
    Cancer; 2012 Sep; 118(18):4369. PubMed ID: 22952030
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer prevention (AUGUST 2009).
    Keller DL
    Cleve Clin J Med; 2009 Nov; 76(11):630; author reply 630. PubMed ID: 19884290
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.
    van Gils MP; Hessels D; Peelen WP; Vergunst H; Mulders PF; Schalken JA
    Prostate; 2009 Nov; 69(15):1624-34. PubMed ID: 19588525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's wrong with chemoprevention of prostate cancer?
    Justman S
    Am J Bioeth; 2011 Dec; 11(12):21-5. PubMed ID: 22146025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dutasteride and prostate cancer.
    Kiemeney LA; Bosland MC
    N Engl J Med; 2010 Aug; 363(8):793; author reply 794-5. PubMed ID: 20718671
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of short-term dutasteride intake in early-stage prostate cancer: analysis of 148 patients who underwent three-dimensional prostate mapping biopsy.
    Barqawi AB; O'Donnell CI; Siomos VJ; Hou AH
    Urology; 2010 Nov; 76(5):1067-71. PubMed ID: 20472268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.
    van Leeuwen PJ; Kölble K; Huland H; Hambrock T; Barentsz J; Schröder FH
    Eur Urol; 2011 Feb; 59(2):183-90. PubMed ID: 21130560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of 5-alpha reductase inhibitors in chemoprevention.
    White WM; Kim ED
    Nat Rev Clin Oncol; 2010 Sep; 7(9):487-8. PubMed ID: 20798697
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.
    Schmidt LJ; Tindall DJ
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):32-8. PubMed ID: 20883781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.